000 01495nas a22003495i 4500
001 1559-131X
003 DE-He213
005 20260610082527.0
007 cr nn 008mamaa
008 150723s||||||||xxuuu poo|||||| b|EN |d
022 _a1559-131X
024 7 _a10.1007/12032.1559-131X
_2doi
210 1 0 _aMed Oncol
245 1 0 _aMedical Oncology
_h[electronic resource] /
_cedited by Kenneth J. Pienta, Sarah R. Amend.
264 1 _aNew York :
_bSpringer US :
_bImprint: Springer.
300 _bonline resource.
520 _aMedical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.     .
650 0 _aOncology.
650 0 _aHematology.
650 0 _aPathology.
650 0 _aInternal medicine.
650 1 4 _aOncology.
650 2 4 _aHematology.
650 2 4 _aPathology.
650 2 4 _aInternal Medicine.
700 1 _aPienta, Kenneth J.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aAmend, Sarah R.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
776 0 8 _iPrinted version:
_x1357-0560
856 4 0 _uhttps://doi.org/10.1007/12032.1559-131X
_zHybrid
999 _c3984
_d3984